Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):311-20

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):311-20

DOI: 10.23736/S1824-4785.17.02961-2

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma

Pierre VERA 1 , Agathe EDET-SANSON 1, Farzaneh QUIEFFIN 2, Joseph LE CLOIREC 1, Anne-Sophie BERTRAND 1, Martin CAILLEAUX 1, Jean-Francois MENARD 2, Charlotte LUSSEY-LEPOUTRE 3, 4, Francoise CALLONNEC 1

1 Department of Nuclear Medicine and Radiology, Henri Becquerel Centre & Quant.I.F - LITIS (Equipe d’Accueil) 4108 - Fédération de Recherche CNRS 3638, Faculty of Medicine, University of Rouen, Rouen, France; 2 Department of Statistics, Rouen University Hospital, Rouen, France; 3 Thyroid and Endocrine Tumors Unit, Department of Nuclear Medicine, Pitié-Salpêtrière Hospital, Paris VI University, Cancer Institute, Paris, France; 4 INSERM, UMR970, Paris-Cardiovascular Research Center at HEGP, Paris, France


PDF


BACKGROUND: Management of patients with well-differentiated thyroid carcinoma (WDTC) and positive thyroglobulin (Tg)/negative iodine-131 whole body scintigraphy (WBS) remains challenging. Here, we investigate the specific role of diffusion-weighted magnetic resonance imaging of the neck (DW-MRI) as compared to rhTSH stimulated FDG-PET/CT in such patients.
METHODS: Patients with WDTC, positive Tg/negative WBS were prospectively enrolled in the study. FDG-PET/CT and neck DW-MRI were performed on the same day after rhTSH stimulation. Neck-US was performed 24 hours after FDG-PET/CT and MRI to guide fine-needle aspiration (FNA). Patients with positive FNA underwent surgery. Patient with negative workup underwent new explorations at 6 and 18 months.
RESULTS: A total of 86 FDG-PET/CT and 83 DW-MRI tests were performed in 40 patients (23 females; 17 males; 52±16 years). For detection of neck recurrences, sensitivity was equivalent for FDG-PET/CT and to DW-MRI at baseline (46% vs. 43%), at 6 months (30% vs. 20%) and at 18 months (11 vs. 10%). The comparison with a non-weighted Kappa test shows significant concordance between FDG-PET/CT and DW-MRI (K=0.741±0.062; P<0.0001). A relationship was observed between Tg and results of FDG-PET/CT, but not for DW-MRI. FDG-PET/CT permitted to detect iodine-refractory distant metastasis in 4 patients.
CONCLUSIONS: In Tg-positive/WBS-negative DTC patients, low tumour burden, neck DW-MRI does not provide additional information compared to rhTSH-stimulated FDG-PET/CT. FDG-PET/CT has the best sensitivity, is acceptable for patients, allows whole body exploration and distant metastasis detections, and is correlated with Tg levels.


KEY WORDS: Diffusion-weighted magnetic resonance imaging; Ultrasonography; Neck; Fluorodeoxyglucose F18; Positron-emission tomography; Thyroid neoplasms

inizio pagina